| Dr Granville J Phillips, MD | |
|
212 Hospital Ln, Suite 205, Perryville, MO 63775-1276 | |
| (573) 547-4899 | |
| (573) 547-5388 |
| Full Name | Dr Granville J Phillips |
|---|---|
| Gender | Male |
| Speciality | Obstetrics & Gynecology |
| Location | 212 Hospital Ln, Perryville, Missouri |
| Accepts Medicare Assignments | Does not participate in Medicare Program. He may not accept medicare assignment. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1619951704 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207V00000X | Obstetrics & Gynecology | 35059 (Missouri) | Primary |
| Mailing Address | Practice Location Address |
|---|---|
| Dr Granville J Phillips, MD 212 Hospital Ln, Suite 205, Perryville, MO 63775-1276 Ph: (573) 547-4899 | Dr Granville J Phillips, MD 212 Hospital Ln, Suite 205, Perryville, MO 63775-1276 Ph: (573) 547-4899 |
News Archive
Researchers at Oregon State University and Oregon Health & Science University are working on a treatment that holds great promise for improving the lives of cystic fibrosis patients.
You've been losing all night, and now another bad hand. So why raise? Gambling addiction is a mental disorder characterized by excessive risk-taking despite negative results. Scientific studies using functional MRI - fMRI, a method of looking at active areas of the brain - have previously shown that addicts have altered activity in brain regions related to risk and reward, making them prone to prefer risky choices.
A collaboration between researchers at the School of Biochemistry and Immunology and the Department of Microbiology at Trinity College Dublin has identified a mechanism by which the bacterium Staphylococcus aureus (S. aureus) colonizes our nasal passages. The study, published today in the Open Access journal PLOS Pathogens, shows for the first time that a protein located on the bacterial surface called clumping factor B (ClfB) has high affinity for the skin protein loricrin.
Omeros Corporation today announced dosing of the first patient in a second Phase 2 clinical trial of OMS824, the company's phosphodiesterase 10 (PDE10) inhibitor being developed for the treatment of schizophrenia, Huntington's disease (HD) and other cognitive disorders. The Phase 2 trial will evaluate the tolerability, safety, pharmacokinetics and performance on a battery of tests in patients with symptomatic HD.
A quarter of Scots are likely to visit pubs and bars more often now that Scotland is smokefree - according to a Cancer Research UK survey.
› Verified 3 days ago
Dr. Craig A Frayer, D.O. Obstetrics & Gynecology Medicare: Accepting Medicare Assignments Practice Location: 206 Hospital Ln, Suite 201, Perryville, MO 63775 Phone: 573-547-4899 Fax: 573-547-5388 |